Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn’s and Colitis Congress
Provided By GlobeNewswire
Last update: Feb 4, 2025
AUSTIN, TX and DURHAM, NC, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-related diseases, today announced an upcoming poster presentation at the 2025 Crohn’s and Colitis Congress being held in San Francisco, California from February 6–8, 2025.
Read more at globenewswire.com0.7733
+0.02 (+2.41%)
Find more stocks in the Stock Screener
STTK Latest News and Analysis
12 days ago - ChartmillWhich stocks are moving on Tuesday?Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
12 days ago - ChartmillWondering what's happening in today's pre-market session?As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
13 days ago - ChartmillWondering what's happening in today's after-hours session?The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.
13 days ago - ChartmillWhich stocks are moving on Monday?Here are the top movers in Monday's session, showcasing the stocks with significant price changes.
